Romania enacts a new drug law that allows the use of marijuana derivatives including "resins or plant fragments" for medical purposes. This makes Romania the 10th country in Europe permitting cannabis products for medical purposes. Prior to the amendment any product containing cannabis or any of its derivatives was completely unlawful. Fortunately the legislators in Bucharest recognized the undeniable efficacy of cannabis in treating chronic pain and in reducing seizures in diseases including epilepsy, cancer, multiple sclerosis and certain other conditions. Studies in Romania are currently underway to determine the efficacy of using cannabis for Alzheimer's disease, Parkinson's disease and Tourette syndrome.
Manufacturers will have to apply to the Romanian National Agency for Medicines for official approval of their medications before they are allowed to market their drugs containing cannabis by-products like resins, oils or concentrates.
The use and possession of cannabis for recreational use remains illegal, but the legislative text is somehow vague - does the term "plant fragments" include the use of the flowers for medical use? But apart from that question it is great news for all affected patients to know they can now get access to means based on a natural resource. Hopefully many countries will follow and break the curse of blinders thinking.